Cistanche tubulosa
Species
KNApSAcK Entry
| Organism name | Cistanche tubulosa |
|---|---|
| Genus | Cistanche |
| Family | Orobanchaceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Cistanche tubulosa |
|---|---|
| Linked NCBI taxonomy ID | 161397 |
| Linked level | species |
Family
| Family in NCBI taxonomy | Orobanchaceae |
|---|---|
| ID | 91896 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | asterids |
|---|---|
| ID | 71274 |
Metabolite list (22)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00002631
|
(+)-Lirioresinol B
/ (+)-Syringaresinol |
CHEMBL361362
CHEMBL402653 |
C042192
|
1 / 0 / 0 | No. 38 | No. 21 |
|
|
|
C00007190
|
(+)-Pinoresinol
|
CHEMBL267963
CHEMBL487611 CHEMBL460862 |
C103298
|
7 / 5 / 6 | No. 38 | No. 21 |
|
|
|
C00030588
|
Kankanoside B
/ (-)-Kankanoside B |
No. 64 | No. 36 |
|
||||
|
C00029601
|
8-Epiloganic acid
/ 8-epi-Loganic acid |
CHEMBL1081585
CHEMBL1079678 CHEMBL1356464 CHEMBL1452775 |
6 / 8 / 7 | No. 64 | No. 36 |
|
||
|
C00010602
|
Gluroside
|
No. 64 | No. 36 |
|
||||
|
C00010517
|
6-Deoxycatalpol
|
No. 64 | No. 36 |
|
||||
|
C00010629
|
Mussaenosidic acid
|
No. 64 | No. 36 |
|
||||
|
C00010600
|
Ajugol
/ Leonuride |
CHEMBL595516
|
No. 64 | No. 36 |
|
|||
|
C00030587
|
Kankanoside A
/ (-)-Kankanoside A |
No. 64 | No. 36 |
|
||||
|
C00010564
|
Geniposidic acid
|
CHEMBL460031
|
C058966
|
No. 100 | No. 36 |
|
||
|
C00010496
|
Bartsioside
|
No. 100 | No. 36 |
|
||||
|
C00010481
|
Antirride
/ Antirrhide |
No. 100 | No. 36 |
|
||||
|
C00001165
|
Mannitol
/ D-Mannitol |
CHEMBL16105
CHEMBL689 CHEMBL1682 CHEMBL1735282 CHEMBL1773904 |
D008353
|
101 / 49 / 42 | 10 / 42 | No. 630 |
|
|
|
C00029317
|
(2E,6Z)-8-beta-D-glucopyranosyloxy-2,6-dimethyl-2,6-octadienoic acid
|
No. 650 |
|
|||||
|
C00030591
|
Kankanoside E
/ (-)-Kankanoside E |
No. 650 |
|
|||||
|
C00010530
|
Cistachlorin
/ cis-Tachlorin / (+)-Cistachlorin |
No. 787 |
|
|||||
|
C00030586
|
Kankanol
/ (+)-Kankanol |
No. 787 |
|
|||||
|
C00010529
|
Cistanin
|
No. 787 |
|
|||||
|
C00019674
|
Uridine
|
CHEMBL68846
CHEMBL100259 CHEMBL265701 CHEMBL608294 CHEMBL609651 CHEMBL1092065 CHEMBL2093066 |
D014529
|
5 / 0 / 3 | 7 / 15 | No. 2366 |
|
|
|
C00029722
|
Argyol
|
No. 2521 |
|
|||||
|
C00030590
|
Kankanoside D
/ (-)-Kankanoside D |
No. 3590 |
|
|||||
|
C00030589
|
Kankanoside C
/ (-)-Kankanoside C |
No. 3854 |
|
Human Protein / Gene in interactions
116 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001165 C00007190 C00019674 | 0 / 3 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001165 C00029601 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00001165 C00019674 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001165 | 0 / 0 |
| P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00001165 | 0 / 0 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001165 | 1 / 0 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001165 | 2 / 2 |
| P08246 | Neutrophil elastase | S1A | C00001165 | 2 / 1 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00001165 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001165 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001165 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00001165 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00001165 | 0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00001165 | 0 / 0 |
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00007190 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00001165 | 2 / 2 |
| O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001165 | 0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | C00001165 | 11 / 10 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00001165 | 1 / 2 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001165 | 0 / 1 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001165 | 1 / 1 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00001165 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00001165 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001165 | 1 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001165 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001165 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001165 | 0 / 0 |
| P08183 | Multidrug resistance protein 1 | drug | C00001165 | 1 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001165 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00001165 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001165 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001165 | 0 / 1 |
| P60033 | CD81 antigen | Unclassified protein | C00029601 | 1 / 1 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001165 | 1 / 8 |
| P11387 | DNA topoisomerase 1 | Isomerase | C00002631 | 0 / 0 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00001165 | 2 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001165 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001165 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00001165 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001165 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00001165 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001165 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001165 | 1 / 1 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001165 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001165 | 1 / 0 |
| P27708 | CAD protein | Enzyme | C00019674 | 0 / 0 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001165 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00001165 | 0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001165 | 0 / 0 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00029601 | 2 / 0 |
| P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00007190 | 0 / 0 |
| Q9HA47 | Uridine-cytidine kinase 1 | Enzyme | C00019674 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001165 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001165 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00001165 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00001165 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00001165 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00001165 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00001165 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001165 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00001165 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001165 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001165 | 1 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001165 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00001165 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001165 | 1 / 0 |
| P03956 | Interstitial collagenase | M10A | C00001165 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001165 | 0 / 0 |
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001165 | 0 / 0 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001165 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00001165 | 0 / 1 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001165 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001165 | 0 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001165 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001165 | 2 / 0 |
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00007190 | 5 / 3 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001165 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001165 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00001165 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001165 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001165 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001165 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001165 | 1 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00001165 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001165 | 2 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001165 | 0 / 0 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00007190 | 0 / 0 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001165 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00001165 | 1 / 1 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001165 | 1 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00001165 | 1 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001165 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001165 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00001165 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001165 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00001165 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00001165 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001165 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001165 | 1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001165 | 0 / 1 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001165 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00019674 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00029601 | 4 / 3 |
| P10323 | Acrosin | S1A | C00001165 | 0 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001165 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001165 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00001165 | 0 / 0 |
| Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00007190 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001165 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001165 | 1 / 1 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00001165 | 0 / 1 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001165 | 0 / 0 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00029601 | 1 / 0 |
| P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00029601 | 0 / 3 |
| Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00007190 | 0 / 0 |
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001165 | 1 / 1 |
17 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001165
|
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00001165
|
| 3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00001165
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00001165
|
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00001165
|
| 4878 | NPPA, ANF, ANP, ATFB6, CDD-ANF, PND | natriuretic peptide A |
C00001165
|
| 27250 | PDCD4, H731 | programmed cell death 4 (neoplastic transformation inhibitor) |
C00001165
|
| 5747 | PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK | protein tyrosine kinase 2 (EC:2.7.10.2) |
C00001165
|
| 7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00001165
|
| 7163 | TPD52, D52, N8L, PC-1, PrLZ, hD52 | tumor protein D52 |
C00001165
|
| 356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00019674
|
| 2993 | GYPA, CD235a, GPA, GPErik, GPSAT, HGpMiV, HGpMiXI, HGpSta(C), MN, MNS, PAS-2 | glycophorin A (MNS blood group) |
C00019674
|
| 4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00019674
|
| 9154 | SLC28A1, CNT1, HCNT1 | solute carrier family 28 (concentrative nucleoside transporter), member 1 |
C00019674
|
| 9153 | SLC28A2, CNT2, HCNT2, HsT17153, SPNT1 | solute carrier family 28 (concentrative nucleoside transporter), member 2 |
C00019674
|
| 2030 | SLC29A1, ENT1 | solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
C00019674
|
| 3177 | SLC29A2, DER12, ENT2, HNP36 | solute carrier family 29 (equilibrative nucleoside transporter), member 2 |
C00019674
|
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (59)
| OMIM | preferred title | UniProt |
|---|---|---|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| %606641 | Body mass index; bmi |
P37231
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #609338 | Carotid intimal medial thickness 1 |
P37231
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #114500 | Colorectal cancer; crc |
P84022
|
| #162800 | Cyclic neutropenia |
P08246
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #613496 | Immunodeficiency, common variable, 6; cvid6 |
P60033
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #159900 | Myoclonic dystonia |
P14416
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #601665 | Obesity |
P32245
P37231 |
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #172700 | Pick disease of brain |
P10636
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #112100 | Yt blood group antigen |
P22303
|
KEGG DISEASE (50)
| KEGG | name | UniProt |
|---|---|---|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
| H00082 | Graves' disease |
P01215
(marker)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
|
| H00027 | Ovarian cancer |
P04626
(related)
|
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00032 | Thyroid cancer |
P37231
(related)
|
| H00409 | Type II diabetes mellitus |
P37231
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
| H00088 | Common variable immunodeficiency (CVID) |
P60033
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
Diseases related to CTD interactions
55 disease in interactions with metabolites
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001165
C00019674 |
| D007022 | Hypotension |
C00001165
C00019674 |
| D008579 | Meningioma |
C00001165
|
| D001929 | Brain Edema |
C00001165
|
| D002545 | Brain Ischemia |
C00001165
|
| D002543 | Cerebral Hemorrhage |
C00001165
|
| D003128 | COMA |
C00001165
|
| D003161 | Compartment Syndromes |
C00001165
|
| D006259 | Craniocerebral Trauma |
C00001165
|
| D003875 | Drug Eruptions |
C00001165
|
| D058186 | Acute Kidney Injury |
C00001165
|
| D004487 | Edema |
C00001165
|
| D004660 | Encephalitis |
C00001165
|
| D005901 | Glaucoma |
C00001165
|
| D015812 | Glaucoma, Angle-Closure |
C00001165
|
| D005910 | Glioma |
C00001165
|
| D034381 | Hearing Loss |
C00001165
|
| D006331 | Heart Diseases |
C00001165
|
| D006505 | Hepatitis |
C00001165
|
| D006955 | Hypernatremia |
C00001165
|
| D007008 | Hypokalemia |
C00001165
|
| D007010 | Hyponatremia |
C00001165
|
| D055371 | Acute Lung Injury |
C00001165
|
| D007177 | Inappropriate ADH Syndrome |
C00001165
|
| D019586 | Intracranial Hypertension |
C00001165
|
| D002546 | Ischemic Attack, Transient |
C00001165
|
| D007674 | Kidney Diseases |
C00001165
|
| D053099 | Azotemia |
C00001165
|
| D017202 | Myocardial Ischemia |
C00001165
|
| D009336 | Necrosis |
C00001165
|
| D009401 | Nephrosis |
C00001165
|
| D009422 | Nervous System Diseases |
C00001165
|
| D009846 | Oliguria |
C00001165
|
| D054038 | Posterior Leukoencephalopathy Syndrome |
C00001165
|
| D011654 | Pulmonary Edema |
C00001165
|
| D011655 | Pulmonary Embolism |
C00001165
|
| D051437 | Renal Insufficiency |
C00001165
|
| D015427 | Reperfusion Injury |
C00001165
|
| D012769 | Shock |
C00001165
|
| D020521 | Stroke |
C00001165
|
| D014581 | Urticaria |
C00001165
|
| D014693 | Ventricular Fibrillation |
C00001165
|
| D000015 | Abnormalities, Multiple |
C00019674
|
| D000749 | Anemia, Megaloblastic |
C00019674
|
| D001919 | Bradycardia |
C00019674
|
| D002375 | Catalepsy |
C00019674
|
| D004342 | Drug Hypersensitivity |
C00019674
|
| D056486 | Drug-Induced Liver Injury |
C00019674
|
| D005234 | Fatty Liver |
C00019674
|
| D028361 | Mitochondrial Diseases |
C00019674
|
| C538525 | Mitochondrial encephalopathy |
C00019674
|
| D017240 | Mitochondrial Myopathies |
C00019674
|
| D010523 | Peripheral Nervous System Diseases |
C00019674
|
| D011565 | Psoriasis |
C00019674
|
| D019956 | Stereotypic Movement Disorder |
C00019674
|